Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Allergy Relief Chlorpheniramine maleate 4 mg Tablet, 100-count — NDC 70677-1016-1 (Billing 70677-1016-01)
by Strategic Sourcing Services LLC · 1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC
This is a package of 100 tablets of Allergy Relief Chlorpheniramine maleate 4 mg Tablet from Strategic Sourcing Services LLC, marketed since Apr 2023 and currently FDA-listed; retail pharmacies pay about $0.0177 per tablet (NADAC). It is this product's only package size.
NDC 70677-1016-01
🏷️ FDA NDC (as labeled)
70677-1016-1
billing pads the package segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 70677-1016-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 70677 labeler · 1016 product · 1 package
- Package marketed since
- Apr 22, 2023
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Billing quantity
- 100 EA per package
- Barcode (UPC)
- 0010939955319
- Medicaid fills, this package
- 232 prescriptions in the last four reported quarters
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
70677-1016-1
Product NDC
70677-1016
11-digit billing NDC
70677101601
NCPDP billing unit
EA — each (per item)
RxCUI
1363309
UNII
V1Q0O9OJ9Z
UPC
0010939955319
Application #
M012
SPL Set ID
c9fa8d93-d9d6-4206-a13d-32b9e7555e7f
Established class (EPC)
Histamine-1 Receptor Antagonist
Mechanism of action
Histamine H1 Receptor Antagonists
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-04-22
Route
ORAL
Dosage form
TABLET
Substance
CHLORPHENIRAMINE MALEATE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
41100020150310
GCN Seq No
011640
GCN
46512
HICL code
004505
Ingredient (HICL)
Chlorpheniramine Maleate
HIC1 code
Z
Therapeutic class — broad (HIC1)
Body As A Whole
HIC2 code
Z2
Therapeutic class — intermediate (HIC2)
Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code
Z2P
Therapeutic class — specific (HIC3)
Antihistamines - 1St Generation
AHFS code
04:04.00.00
AHFS class
First Generation Antihistamines
FDB label name
FT ALLERGY (CHLORPHEN) 4 MG TB
FDB brand name
Allergy Relief
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 011640
- GCN: 46512
- GPI-14 (Medi-Span): 41100020150310
- HICL (First Databank): 004505
- AHFS class code: 04:04.00.00
- RxCUI (RxNorm): 1363309
Why two NDCs?
The FDA registers this code as 70677-1016-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1016-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the Histamine-1 Receptor Antagonist class.
Pharmacologic class
Histamine-1 Receptor Antagonist
Drug family (ATC)
Substituted alkylamines
How it works
Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Label name FT ALLERGY (CHLORPHEN) 4 MG TB Ingredient Chlorpheniramine Maleate
📖 What it is MedlinePlus · NLM
Chlorpheniramine is used to treat allergy symptoms: sneezing runny nose itchy nose or throat red, itchy, watery eyes Chlorpheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- It temporarily relieves allergy symptoms from hay fever and other upper respiratory allergies. That means sneezing, runny nose, itchy, watery eyes, and an itchy nose or throat. It...
- It depends on the product. Regular tablets and the liquid are generally taken every 4 to 6 hours. The extended-release tablets are taken about every 12 hours. Check your package fo...
- It can, and the drowsiness may be marked. Be careful driving or using machinery. Some people, especially children, can get excitable instead.
- It's best to avoid alcohol, since it adds to drowsiness. Sedatives and tranquilizers can also increase drowsiness, so talk to me or your doctor before taking them together.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
💬 Questions about Chlorpheniramine maleate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.018 | $1.77 / 100 tablets |
| Medicaid paysCMS SDUD · 12 mo | $0.3058 | $30.58 / 100 tablets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▲ Up 7% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file · file of Sep 30, 2026
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q1 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70677-1016-01 You're viewing this Main listing | 1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC | 2023-04-22 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Allergy Relief 4 Hour 4 mg 70000-0160-01 | Cardinal | 24 tablets | $0.018 | — | Discontinued | save 1% |
| Allergy 4 mg 00904-0012-24 | Major | 24 tablets | $0.018 | — | Availability likely | — |
| Allergy Relief 4 mg 46122-0618-62 | Amerisource | 24 tablets | $0.018 | — | Availability likely | — |
| Allergy Relief 4 mgthis 70677-1016-01 | Strategic | 100 tablets | $0.018 | — | Availability likely | — |
| Allergy Relief 4 mg 83324-0068-24 | Chain | 24 tablets | $0.018 | — | Availability likely | — |
| Aller-chlor 4 mg 00536-1006-01 | Rugby | 100 tablets | $0.018 | — | Availability likely | — |
| Allergy Relief 4 mg 00363-1941-15 | Walgreen | 50 tablets | — | — | FDA listed | — |
| allergy relief 4 mg 11822-0662-01 | Rite | 100 tablets | — | — | FDA listed | — |
| Anti Allergy 4 mg 17714-0016-01 | Advance | 100 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 36800-0694-08 | Topco | 24 tablets | — | — | FDA listed | — |
| Allergy 4 mg 37835-0633-01 | Bi-Mart | 100 tablets | — | — | FDA listed | — |
| Allergy 4 mg 41163-0194-08 | United | 24 tablets | — | — | FDA listed | — |
| Medique Chlorphen 4 mg 47682-0169-46 | Unifirst | 1 tablet | — | — | FDA listed | — |
| Allergy Time 4 mg 49483-0242-00 | Time | 100000 tablets | — | — | FDA listed | — |
| Allergy 4 mg 50090-0049-00 | A-S | 100 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 50804-0277-93 | Good | 24 tablets | — | — | FDA listed | — |
| Sprinsol 4 mg 51467-0101-01 | FORTUNE | 24 tablets | — | — | FDA listed | — |
| Chlorpheniramine maleate 4mg 4 mg 53185-0277-24 | Athlete's | 24 tablets | — | — | FDA listed | — |
| Anti Allergy 4 mg 54738-0103-01 | Richmond | 100 tablets | — | — | FDA listed | — |
| Chlorpheniramine Maleate 4 mg 55289-0560-01 | PD-Rx | 100 tablets | — | — | FDA listed | — |
| Allergy Relief 4 Hour 4 mg 57896-0974-01 | Geri-Care | 100 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 63868-0333-24 | CHAIN | 24 tablets | — | — | FDA listed | — |
| Allergy Relief 4 Hour 4 mg 67091-0203-24 | WinCo | 24 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 68016-0683-81 | Chain | 100 tablets | — | — | FDA listed | — |
| Allergy 4 mg 68998-0277-93 | Marc | 24 tablets | — | — | FDA listed | — |
| Allergy 4 mg 69168-0277-93 | Allegiant | 24 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 69842-0194-12 | CVS | 100 tablets | — | — | FDA listed | — |
| Chlorpheniramine Maleate 4 mg 71335-0963-01 | Bryant | 30 tablets | — | — | FDA listed | — |
| Allergy 4 mg 71335-2056-01 | Bryant | 30 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 71335-2812-01 | Bryant | 100 tablets | — | — | FDA listed | — |
| Allergy Relief 4 Hour 4 mg 71335-3093-01 | Bryant | 30 tablets | — | — | FDA listed | — |
| Pharbechlor 4 mg 73057-0346-11 | Ulai | 1000 tablets | — | — | FDA listed | — |
| Allergy Relief 4 mg 79903-0074-12 | WALMART | 100 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file · file of Sep 30, 2026
Availability & generic status
🏛️
2023
On the market since
Apr 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
yellow
ShapeRound
Imprint44;194
Size8 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Chlorpheniramine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3SY5LH9PMK
Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
-
UNII CQ3XH3DET6
D&C Yellow No. 10 Aluminum Lake is a yellow colorant made by combining a dye with aluminum salts. It's used in medicines to add color for product identification and visual appeal.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
5 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statescorn starch, D&C yellow #10 aluminum lake, lactose anhydrous, magnesium stearate, microcrystalline cellulose
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerStrategic Sourcing Services LLC
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedApr 2023
Product typeHuman Otc Drug
Portfolio316 products on file
More NDCs from Strategic Sourcing Services LLC labeler code 70677
- Fexofenadine Hydrochloride and Pseudoephedrine 60 mg; 120 mg Tablet, Extended Release NDC 70677-1010-1
- Guaifenesin and Pseudoephedrine HCl 600 mg; 60 mg Tablet, Extended Release NDC 70677-1011-1
- Foster and Thrive Childrens Allergy Relief Diphenhydramine HCl 12.5 mg/5mL Liquid NDC 70677-1012-1
- Foster and Thrive Mucus Relief Guaifenesin 600 mg Tablet, Extended Release NDC 70677-1013-1
- Allergy Relief Diphenhydramine HCl 25 mg Tablet, Film Coated NDC 70677-1014-1
- Allergy Relief Diphenhydramine HCl 25 mg Capsule NDC 70677-1015-1
- Nasal Decongestant Maximum Strength Pseudoephedrine HCl 30 mg Tablet, Film Coated NDC 70677-1017-1
- Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release NDC 70677-1018-1
- Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated NDC 70677-1019-1
- Allergy relief-D Cetirizine Hydrochloride and Pseudoephedrine 5 mg; 120 mg Tablet, Film Coated, Extended Release NDC 70677-1020-1
- Foster and Thrive Allergy Relief Fluticasone propionate 50 ug Spray, Metered NDC 70677-1021-1
- foster and thrive allergy relief Loratadine 10 mg Tablet NDC 70677-1022-1
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 Ask a Doctor Before Use If
📄 Ask a Doctor or Pharmacist Before Use If
📄 When Using This Product
🤰 If Pregnant or Breast-Feeding
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat
⏱️ Dosage and Administration ▾
Directions take every 4 to 6 hours, or as directed by a doctor adults and children 12 years and over 1 tablet. Do not exceed 6 tablets in 24 hours. children 6 to under 12 years 1/2 tablet (break tablet in half). Do not exceed 3 whole tablets in 24 hours. children under 6 years do not use
⚠️ Warnings ▾
Warnings Do not use to make a child sleepy. Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product drowsiness may occur avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery alcohol, sedatives, and tranquilizers may increase drowsiness excitability may occur, especially in children If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) protect from excessive moisture see end flap for expiration date and lot number
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Chlorpheniramine maleate 4 mg
🧪 Inactive Ingredients ▾
Inactive ingredients corn starch, D&C yellow #10 aluminum lake, lactose anhydrous, magnesium stearate, microcrystalline cellulose
🎯 Purpose ▾
Purpose Antihistamine
📄 Do Not Use ▾
Do not use to make a child sleepy.
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis difficulty in urination due to enlargement of the prostate gland
📄 Ask a Doctor or Pharmacist Before Use If ▾
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
📄 When Using This Product ▾
When using this product drowsiness may occur avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery alcohol, sedatives, and tranquilizers may increase drowsiness excitability may occur, especially in children
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions or comments? Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST
📄 Package Label / Principal Display Panel ▾
Principal Display Panel NDC 70677-1016-1 Foster & Thrive™ Allergy Relief Chlorpheniramine maleate 4 mg ANTIHISTAMINE 4 hour relief of: • Sneezing • Runny Nose • Itchy, Watery Eyes and Itchy Throat ACTUAL SIZE 100 TABLETS TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING 50844 ORG041919412 Rev. 02/23 ©2023 McKesson Corporation Distributed by: McKesson Corp., via Strategic Sourcing Services LLC., Memphis, TN 38141 Money Back Guarantee www.fosterandthrive.com Foster and Thrive 44-194 Foster and Thrive 44-194
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
232
Units reimbursed last 4 qtrs
9.4K
Gross reimbursed last 4 qtrs
$2.9K
Avg / prescription
$12.37
Avg / unit
$0.3058
Latest quarter Q1 2026
86Rx
Medicaid pays / ea
$0.3058
gross reimbursed
vs
NADAC / ea
$0.0177
acquisition cost
=
Spread
+$0.2881
+1628% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 232 Rx Managed care · 0 Rx
State Medicaid map
Units reimbursed · per 100k residents
20.4103
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.